{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:33:52Z","timestamp":1791988432618,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hangzhou biomedical and health industry development support project","award":["2021WJCY159"],"award-info":[{"award-number":["2021WJCY159"]}]},{"name":"Hangzhou medical key discipline construction project","award":["No [37]21-3"],"award-info":[{"award-number":["No [37]21-3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"DOI":"10.1007\/s10103-024-04066-3","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T02:01:30Z","timestamp":1714356090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Definition of refractory melasma and its treatment: a review"],"prefix":"10.1007","volume":"39","author":[{"given":"Huiyi","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangfeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuzu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3619-7741","authenticated-orcid":false,"given":"Wenzhong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"key":"4066_CR1","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1080\/0954663420211914313","volume":"33","author":"N Neagu","year":"2022","unstructured":"Neagu N, Conforti C, Agozzino M, Marangi GF, Morariu SH, Pellacani G et al (2022) Melasma treatment: a systematic review. J Dermatolog Treat 33:1816\u20131837. https:\/\/doi.org\/10.1080\/09546634.2021.1914313","journal-title":"J Dermatolog Treat"},{"key":"4066_CR2","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/j.1524-4725.2004.30371.x","volume":"30","author":"CC Wang","year":"2004","unstructured":"Wang CC, Hui CY, Sue YM, Wong WR, Hong HS (2004) Intense pulsed light for the treatment of refractory melasma in Asian persons. Dermatol Surg 30:1196\u20131200. https:\/\/doi.org\/10.1111\/j.1524-4725.2004.30371.x","journal-title":"Dermatol Surg"},{"key":"4066_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4103\/ijdvl.IJDVL_633_18","volume":"86","author":"R Sarkar","year":"2020","unstructured":"Sarkar R, Bansal A, Ailawadi P (2020) Future therapies in melasma: what lies ahead? Indian J Dermatol Venereol Leprol 86:8\u201317. https:\/\/doi.org\/10.4103\/ijdvl.IJDVL_633_18","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"4066_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1046\/j.1524-4725.2003.29009.x","volume":"29","author":"S Angsuwarangsee","year":"2003","unstructured":"Angsuwarangsee S, Polnikorn N (2003) Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: split-face design. Dermatol Surg 29:59\u201364. https:\/\/doi.org\/10.1046\/j.1524-4725.2003.29009.x","journal-title":"Dermatol Surg"},{"key":"4066_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j1468-3083201104135x","volume":"26","author":"I Arellano","year":"2012","unstructured":"Arellano I, Cestari T, Ocampo-Candiani J, Azulay-Abulafia L, Bezerra Trindade Neto P, Hexsel D et al (2012) Preventing melasma recurrence: prescribing a maintenance regimen with an effective triple combination cream based on long-standing clinical severity. J Eur Acad Dermatol Venereol 26:611\u2013618. https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04135.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4066_CR6","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.1524-4725.1994.tb00152.x","volume":"20","author":"CR Taylor","year":"1994","unstructured":"Taylor CR, Anderson RR (1994) Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol 20:592\u2013597. https:\/\/doi.org\/10.1111\/j.1524-4725.1994.tb00152.x","journal-title":"J Dermatol Surg Oncol"},{"key":"4066_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1046\/j1524-4725199908103x","volume":"25","author":"RM Manaloto","year":"1999","unstructured":"Manaloto RM, Alster T (1999) Erbium:YAG laser resurfacing for refractory melasma. Dermatol Surg 25:121\u2013123. https:\/\/doi.org\/10.1046\/j.1524-4725.1999.08103.x","journal-title":"Dermatol Surg"},{"key":"4066_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/lsm.20591","volume":"40","author":"DJ Goldberg","year":"2008","unstructured":"Goldberg DJ, Berlin AL, Phelps R (2008) Histologic and ultrastructural analysis of melasma after fractional resurfacing. Lasers Surg Med 40:134\u2013138. https:\/\/doi.org\/10.1002\/lsm.20591","journal-title":"Lasers Surg Med"},{"key":"4066_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/14764170802179687","volume":"10","author":"N Polnikorn","year":"2008","unstructured":"Polnikorn N (2008) Treatment of refractory dermal melasma with the MedLite C6 Q-switched nd:YAG laser: two case reports. J Cosmet Laser Ther 10:167\u2013173. https:\/\/doi.org\/10.1080\/14764170802179687","journal-title":"J Cosmet Laser Ther"},{"key":"4066_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/ijd.12477","volume":"54","author":"E Attwa","year":"2015","unstructured":"Attwa E, Khater M, Assaf M, Haleem MA (2015) Melasma treatment using an erbium:YAG laser: a clinical, immunohistochemical, and ultrastructural study. Int J Dermatol 54:235\u2013244. https:\/\/doi.org\/10.1111\/ijd.12477","journal-title":"Int J Dermatol"},{"key":"4066_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/dss.0000000000003367","volume":"48","author":"BJ Park","year":"2022","unstructured":"Park BJ, Jung YJ, Ro YS, Chang SE, Kim JE (2022) Therapeutic effects of New Pulsed-Type Microneedling Radiofrequency for Refractory Facial Pigmentary disorders. Dermatol Surg 48:327\u2013333. https:\/\/doi.org\/10.1097\/dss.0000000000003367","journal-title":"Dermatol Surg"},{"key":"4066_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/14764172.2019.1605447","volume":"21","author":"S Garg","year":"2019","unstructured":"Garg S, Vashisht KR, Makadia S (2019) A prospective randomized comparative study on 60 Indian patients of melasma, comparing pixel Q-switched NdYAG (1064 nm), super skin rejuvenation (540 nm) and ablative pixel erbium YAG (2940 nm) lasers, with a review of the literature. J Cosmet Laser Ther 21:297\u2013307. https:\/\/doi.org\/10.1080\/14764172.2019.1605447","journal-title":"J Cosmet Laser Ther"},{"key":"4066_CR13","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1002\/lsm.23059","volume":"51","author":"N Polnikorn","year":"2019","unstructured":"Polnikorn N, Tanghetti EA (2019) Treatment of refractory melasma in asians with flat and diffractive lens picosecond alexandrite laser. Lasers Surg Med 51:S49\u2013S50. https:\/\/doi.org\/10.1002\/lsm.23059","journal-title":"Lasers Surg Med"},{"key":"4066_CR14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1524-4725.2009.01383.x","volume":"36","author":"P Wattanakrai","year":"2010","unstructured":"Wattanakrai P, Mornchan R, Eimpunth S (2010) Low-fluence Q-Switched neodymium-doped Yttrium Aluminum Garnet (1,064 nm) laser for the Treatment of Facial Melasma in asians. Dermatol Surg 36:76\u201387. https:\/\/doi.org\/10.1111\/j.1524-4725.2009.01383.x","journal-title":"Dermatol Surg"},{"key":"4066_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1529-8019.2012.01530.x","volume":"25","author":"L Figueiredo Souza","year":"2012","unstructured":"Figueiredo Souza L, Trancoso Souza S (2012) Single-session intense pulsed light combined with stable fixed-dose triple combination topical therapy for the treatment of refractory melasma. Dermatol Ther 25:477\u2013480. https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01530.x","journal-title":"Dermatol Ther"},{"key":"4066_CR16","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s10103-020-03045-8","volume":"35","author":"R Wanitphakdeedecha","year":"2020","unstructured":"Wanitphakdeedecha R, Sy-Alvarado F, Patthamalai P, Techapichetvanich T, Eimpunth S, Manuskiatti W (2020) The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study. Lasers Med Sci 35:2015\u20132021. https:\/\/doi.org\/10.1007\/s10103-020-03045-8","journal-title":"Lasers Med Sci"},{"key":"4066_CR17","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1080\/09546634.2021.1968996","volume":"33","author":"F Mokhtari","year":"2022","unstructured":"Mokhtari F, Bahrami B, Faghihi G, Asilian A, Iraji F (2022) Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial. J Dermatolog Treat 33:2475\u20132481. https:\/\/doi.org\/10.1080\/09546634.2021.1968996","journal-title":"J Dermatolog Treat"},{"key":"4066_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15641","author":"AM Beyzaee","year":"2023","unstructured":"Beyzaee AM, Goldust M, Rokni GR, Patil A, Mostaghiman R, Golpour M (2023) Comparative effectiveness and safety of topical methimazole 5% monotherapy versus combination of Q-Switched nd: YAG Laser and topical methimazole 5% in patients with refractory melasma. J Cosmet Dermatol. https:\/\/doi.org\/10.1111\/jocd.15641","journal-title":"J Cosmet Dermatol"},{"key":"4066_CR19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/dth.12250","volume":"28","author":"PR Cunha","year":"2015","unstructured":"Cunha PR, Pinto CA, Mattos CB, Cabrini DP, Tolosa JL (2015) New insight in the treatment of refractory melasma: laser Q-switched nd: YAG non-ablative fractionated followed by intense pulsed light. Dermatol Ther 28:296\u2013299. https:\/\/doi.org\/10.1111\/dth.12250","journal-title":"Dermatol Ther"},{"key":"4066_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3109\/14764172.2015.1063662","volume":"18","author":"WCBA Tian","year":"2016","unstructured":"Tian WCBA (2016) Novel technique to treat melasma in Chinese: the combination of 2940-nm fractional Er:YAG and 1064-nm Q-switched nd:YAG laser. J Cosmet Laser Therapy 18:72\u201374. https:\/\/doi.org\/10.3109\/14764172.2015.1063662","journal-title":"J Cosmet Laser Therapy"},{"key":"4066_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4103\/jcas.Jcas_30_20","volume":"14","author":"L Hai","year":"2021","unstructured":"Hai L, Phuong B, Ha L, Lam V, Van B, Al-Niaimi F (2021) Dual Toning Method with the combination of Picosecond and Microsecond Nd:YAG in Refractory Melasma unresponsive to Picosecond alone. J Cutan Aesthet Surg 14:101\u2013106. https:\/\/doi.org\/10.4103\/jcas.Jcas_30_20","journal-title":"J Cutan Aesthet Surg"},{"key":"4066_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3109\/14764172.2010.487910","volume":"12","author":"N Polnikorn","year":"2010","unstructured":"Polnikorn N (2010) Treatment of refractory melasma with the MedLite C6 Q-switched nd:YAG laser and alpha arbutin: a prospective study. J Cosmet Laser Ther 12:126\u2013131. https:\/\/doi.org\/10.3109\/14764172.2010.487910","journal-title":"J Cosmet Laser Ther"},{"key":"4066_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/lsm.21156","volume":"44","author":"ANB Kauvar","year":"2012","unstructured":"Kauvar ANB (2012) Successful treatment of melasma using a combination of microdermabrasion and Q-switched nd:YAG lasers. Lasers Surg Med 44:117\u2013124. https:\/\/doi.org\/10.1002\/lsm.21156","journal-title":"Lasers Surg Med"},{"key":"4066_CR24","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/dsu.0000000000000029","volume":"40","author":"N Cameli","year":"2014","unstructured":"Cameli N, Abril E, Mariano M, Berardesca E (2014) Combined use of monopolar radiofrequency and transdermal drug delivery in the treatment of melasma. Dermatol Surg 40:748\u2013755. https:\/\/doi.org\/10.1111\/dsu.0000000000000029","journal-title":"Dermatol Surg"},{"key":"4066_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/ijd.12195","volume":"53","author":"ZI Shaikh","year":"2014","unstructured":"Shaikh ZI, Mashood AA (2014) Treatment of refractory melasma with combination of topical 5% magnesium ascorbyl phosphate and fluorescent pulsed light in Asian patients. Int J Dermatol 53:93\u201399. https:\/\/doi.org\/10.1111\/ijd.12195","journal-title":"Int J Dermatol"},{"key":"4066_CR26","doi-asserted-by":"publisher","DOI":"10.17795\/jssc30290","author":"A Zamanian","year":"2015","unstructured":"Zamanian A, Behrangi E, Hossein Ghafarpour G, Mehran G, Espahbodi R, Hoseinzade Fakhim T et al (2015) Effect of hydroquinone plus neodymium-doped yttrium aluminium garnet laser with and without CO2 fractional laser on resistant dermal melasma. J Skin Stem Cell 2. https:\/\/doi.org\/10.17795\/jssc30290","journal-title":"J Skin Stem Cell 2"},{"key":"4066_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jdin.2022.02.010","volume":"8","author":"C Kim","year":"2022","unstructured":"Kim C, Gao JC, Moy J, Lee HS (2022) Fractional CO2 laser and adjunctive therapies in skin of color melasma patients. JAAD Int 8:118\u2013123. https:\/\/doi.org\/10.1016\/j.jdin.2022.02.010","journal-title":"JAAD Int"},{"key":"4066_CR28","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1346-8138.1998.tb02463.x","volume":"25","author":"WH Kang","year":"1998","unstructured":"Kang WH, Chun SC, Lee S (1998) Intermittent therapy for melasma in Asian patients with combined topical agents (retinoic acid, hydroquinone and hydrocortisone): clinical and histological studies. J Dermatol 25:587\u2013596. https:\/\/doi.org\/10.1111\/j.1346-8138.1998.tb02463.x","journal-title":"J Dermatol"},{"key":"4066_CR29","first-page":"732","volume":"8","author":"BM Hantash","year":"2009","unstructured":"Hantash BM, Jimenez F (2009) A split-face, double-blind, randomized and placebo-controlled pilot evaluation of a novel oligopeptide for the treatment of recalcitrant melasma. J Drugs Dermatol 8:732\u2013735","journal-title":"J Drugs Dermatol"},{"key":"4066_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40257-019-00488-w","volume":"21","author":"J McKesey","year":"2020","unstructured":"McKesey J, Tovar-Garza A, Pandya AG (2020) Melasma Treatment: an evidence-based review. Am J Clin Dermatol 21:173\u2013225. https:\/\/doi.org\/10.1007\/s40257-019-00488-w","journal-title":"Am J Clin Dermatol"},{"key":"4066_CR31","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1111\/ajd.12474","volume":"58","author":"AWM Tan","year":"2017","unstructured":"Tan AWM, Sen P, Chua SH, Goh BK (2017) Oral tranexamic acid lightens refractory melasma. Australas J Dermatol 58:e105\u2013e8. https:\/\/doi.org\/10.1111\/ajd.12474","journal-title":"Australas J Dermatol"},{"key":"4066_CR32","doi-asserted-by":"publisher","first-page":"e12704","DOI":"10.1111\/dth.12704","volume":"31","author":"D Nagaraju","year":"2018","unstructured":"Nagaraju D, Bhattacharjee R, Vinay K, Saikia UN, Parsad D, Kumaran MS (2018) Efficacy of oral tranexemic acid in refractory melasma: a clinico-immuno-histopathological study. Dermatol Ther 31:e12704. https:\/\/doi.org\/10.1111\/dth.12704","journal-title":"Dermatol Ther"},{"key":"4066_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1346-8138.2007.00211.x","volume":"34","author":"H Erbil","year":"2007","unstructured":"Erbil H, Sezer E, Ta\u015ftan B, Arca E, Kurumlu Z (2007) Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma. J Dermatol 34:25\u201330. https:\/\/doi.org\/10.1111\/j.1346-8138.2007.00211.x","journal-title":"J Dermatol"},{"key":"4066_CR34","doi-asserted-by":"publisher","first-page":"e1335","DOI":"10.1097\/gox.0000000000001335","volume":"5","author":"T Mashiko","year":"2017","unstructured":"Mashiko T, Oka A, Osawa E, Koshima I (2017) A deceptively simple solution for refractory melasma: glycolic acid peels and hydroquinone at Home. Plast Reconstr Surg Glob Open 5:e1335. https:\/\/doi.org\/10.1097\/gox.0000000000001335","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"4066_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2147\/ccid.S242180","volume":"13","author":"J Piquero-Casals","year":"2020","unstructured":"Piquero-Casals J, Granger C, Piquero-Casals V, Garre A, Mir-Bonaf\u00e9 JF (2020) A treatment combination of peels, oral antioxidants, and topical therapy for refractory melasma: a report of 4 cases. Clin Cosmet Investig Dermatol 13:209\u2013213. https:\/\/doi.org\/10.2147\/ccid.S242180","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"4066_CR36","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1097\/dss.0000000000002763","volume":"46","author":"SZ Wu","year":"2020","unstructured":"Wu SZ, Muddasani S, Alam M (2020) A systematic review of the efficacy and safety of Microneedling in the Treatment of Melasma. Dermatol Surg 46:1636\u20131641. https:\/\/doi.org\/10.1097\/dss.0000000000002763","journal-title":"Dermatol Surg"},{"key":"4066_CR37","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1590\/abd1806-4841.20154748","volume":"90","author":"A Lima Ede","year":"2015","unstructured":"Lima Ede A (2015) Microneedling in facial recalcitrant melasma: report of a series of 22 cases. Bras Dermatol 90:919\u2013921. https:\/\/doi.org\/10.1590\/abd1806-4841.20154748","journal-title":"Bras Dermatol"},{"key":"4066_CR38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/14764172.2017.1342036","volume":"19","author":"P Ustuner","year":"2017","unstructured":"Ustuner P, Balevi A, Ozdemir M (2017) A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched nd:YAG laser plus microneedling with vitamin C versus Q-switched nd:YAG laser for the treatment of recalcitrant melasma. J Cosmet Laser Ther 19:383\u2013390. https:\/\/doi.org\/10.1080\/14764172.2017.1342036","journal-title":"J Cosmet Laser Ther"},{"key":"4066_CR39","first-page":"38","volume":"18","author":"JF Ram\u00edrez-Oliveros","year":"2020","unstructured":"Ram\u00edrez-Oliveros JF, de Abreu L, Tamler C, Vilhena P, de Barros MH (2020) Microneedling with drug delivery (hydroquinone 4% serum) as an adjuvant therapy for recalcitrant Melasma. Skinmed 18:38\u201340","journal-title":"Skinmed"},{"key":"4066_CR40","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1111\/jocd.13392","volume":"19","author":"S Shamsi Meymandi","year":"2020","unstructured":"Shamsi Meymandi S, Mozayyeni A, Shamsi Meymandi M, Aflatoonian M (2020) Efficacy of microneedling plus topical 4% tranexamic acid solution vs 4% hydroquinone in the treatment of melasma: a single-blind randomized clinical trial. J Cosmet Dermatol 19:2906\u20132911. https:\/\/doi.org\/10.1111\/jocd.13392","journal-title":"J Cosmet Dermatol"},{"key":"4066_CR41","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/jocd.14644","volume":"21","author":"M Khalili","year":"2022","unstructured":"Khalili M, Amiri R, Iranmanesh B, Zartab H, Aflatoonian M (2022) Safety and efficacy of mesotherapy in the treatment of melasma: a review article. J Cosmet Dermatol 21:118\u2013129. https:\/\/doi.org\/10.1111\/jocd.14644","journal-title":"J Cosmet Dermatol"},{"key":"4066_CR42","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/dss.0000000000001559","volume":"45","author":"S Garg","year":"2019","unstructured":"Garg S, Khillan K, Bharija SC (2019) Platelet-Rich plasma therapy in the treatment of recalcitrant Melasma. Dermatol Surg 45:482\u2013484. https:\/\/doi.org\/10.1097\/dss.0000000000001559","journal-title":"Dermatol Surg"},{"key":"4066_CR43","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jaad.2006.02.009","volume":"55","author":"AK Gupta","year":"2006","unstructured":"Gupta AK, Gover MD, Nouri K, Taylor S (2006) The treatment of melasma: a review of clinical trials. J Am Acad Dermatol 55:1048\u20131065. https:\/\/doi.org\/10.1016\/j.jaad.2006.02.009","journal-title":"J Am Acad Dermatol"},{"key":"4066_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/ajd.12290","volume":"56","author":"M Rodrigues","year":"2015","unstructured":"Rodrigues M, Pandya AG (2015) Melasma: clinical diagnosis and management options. Australas J Dermatol 56:151\u2013163. https:\/\/doi.org\/10.1111\/ajd.12290","journal-title":"Australas J Dermatol"},{"key":"4066_CR45","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/jdv.15497","volume":"33","author":"T Passeron","year":"2019","unstructured":"Passeron T, Genedy R, Salah L, Fusade T, Kositratna G, Laubach HJ et al (2019) Laser treatment of hyperpigmented lesions: position statement of the European Society of Laser in Dermatology. J Eur Acad Dermatol Venereol 33:987\u20131005. https:\/\/doi.org\/10.1111\/jdv.15497","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4066_CR46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s13555-014-0064-z","volume":"4","author":"K Shankar","year":"2014","unstructured":"Shankar K, Godse K, Aurangabadkar S, Lahiri K, Mysore V, Ganjoo A et al (2014) Evidence-based treatment for melasma: expert opinion and a review. Dermatol Ther (Heidelb) 4:165\u2013186. https:\/\/doi.org\/10.1007\/s13555-014-0064-z","journal-title":"Dermatol Ther (Heidelb)"},{"key":"4066_CR47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s13555-017-0194-1","volume":"7","author":"OA Ogbechie-Godec","year":"2017","unstructured":"Ogbechie-Godec OA, Elbuluk N (2017) Melasma: an Up-to-date Comprehensive Review. Dermatol Ther (Heidelb) 7:305\u2013318. https:\/\/doi.org\/10.1007\/s13555-017-0194-1","journal-title":"Dermatol Ther (Heidelb)"},{"key":"4066_CR48","doi-asserted-by":"publisher","first-page":"769","DOI":"10.4103\/idoj.idoj_490_22","volume":"14","author":"R Sarkar","year":"2023","unstructured":"Sarkar R, Handog EB, Das A, Bansal A, Macarayo MJ, Keshavmurthy V et al (2023) Topical and systemic therapies in Melasma: a systematic review. Indian Dermatol Online J 14:769\u2013781. https:\/\/doi.org\/10.4103\/idoj.idoj_490_22","journal-title":"Indian Dermatol Online J"},{"key":"4066_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.det.2023.06.003","volume":"42","author":"R Sarkar","year":"2024","unstructured":"Sarkar R, Katoch S (2024) Chemical peels in treatment of Melasma. Dermatol Clin 42:21\u201332. https:\/\/doi.org\/10.1016\/j.det.2023.06.003","journal-title":"Dermatol Clin"},{"key":"4066_CR50","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s40257-013-0038-4","volume":"14","author":"S Rivas","year":"2013","unstructured":"Rivas S, Pandya AG (2013) Treatment of melasma with topical agents, peels and lasers: an evidence-based review. Am J Clin Dermatol 14:359\u2013376. https:\/\/doi.org\/10.1007\/s40257-013-0038-4","journal-title":"Am J Clin Dermatol"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-024-04066-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-024-04066-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-024-04066-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T15:40:05Z","timestamp":1738338005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-024-04066-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4066"],"URL":"https:\/\/doi.org\/10.1007\/s10103-024-04066-3","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,29]]},"assertion":[{"value":"31 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"118"}}